• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Stromectol (ivermectin) 3 mg Tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- June 2009


Summary View



Post-Marketing experience 

The following adverse reactions have been reported since the drug was registered overseas: 

  • Onchocerciasis:  Conjunctival hemorrhage 
  • All Indications:  hepatitis